PHARM-13 Statement of Medical Necessity for Quantity Limits Override.
Drugs
Quantity Limits
Aerochamber (Inhaler Assistance) Devices
Arixtra (Fondaparinux Sodium) 2.5mg/0.5ml, 5mg/0.4ml, 7.5mg/0.6ml and 10mg/0.8ml Disposable Syringes
Exforge (Amlodipine - Valsartan) 5mg - 160mg, 5mg - 320mg, 10mg - 160mg and 10mg - 320mg Tablets
Exforge HCT (Amlodipine - Valsartan - Hydrochlorothiazide) 5mg - 160mg - 12.5mg, 5mg - 160mg - 25mg, 10mg - 160mg - 12.5mg, 10mg - 160mg - 25mg and 10mg - 320mg - 25mg Tablets
Iressa (Gefitinib) 250mg Tablets
Kenalog (Triamcinolone Acetonide) 10mg/ml and 40mg/ml Vial
Revatio (Sildenafil Citrate) 20mg Tablets
Savella (Milnacipran HCL) DS PK Tablets
12.5mg, 25mg, 50mg and 100mg Tablets
55 Tablets per 28 days
60 Tablets per 30 days
Somatuline Depot (Lanreotide Acetate) Sub-Q Diposable Syringe
Toviaz (Fesoterodine Fumarate) 4mg and 8mg SR Tablets
30 Tablets per 30 Days
Zelapar (Selegiline HCL) 1.25mg Rapdis Tablets
back to top